Fiche société
Université de Sherbrooke
Traitements, essais et publications liés.
Traitements4programmes
Essais2liés
Publications2liées
SourceDBlocale
Traitements
4| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| Effects of a 12-week Strength Training Program in Women With Myotonic Dystrophy Type 120 women with myotonic dystrophy type 1 (DM1) will complete a 12-week lower-limb strength training program. The training program consist of 3 series of 6 to 8 maximal repetitions of 5 different exercises: Leg extension, leg press, hip abduction, squat and plantar flexion. Training sessions will be closely supervise and take place twice a week. It is hypothesize that the training program will induce muscular hypertrophy despite the genetic defect. The training program should also have positive effects on function. The participants will be evaluated at baseline, week 6, week 12, month 6 and month 9 to quantify the effects of the training program and if these effects will be maintained over time. | Myopathies | NA | À vérifier | Canada | À vérifier |
| PET scan metabolic dayThe objective of this study is to nake a comparison between 11c-acetate and 11c-acetoacetate kidney uptake in chronic kidney failure patients. | Maladie rénale chronique | À vérifier | À vérifier | Canada | À vérifier |
| Effects of a 12-week Strength Training Program in Women With Myotonic Dystrophy Type 120 women with myotonic dystrophy type 1 (DM1) will complete a 12-week lower-limb strength training program. The training program consist of 3 series of 6 to 8 maximal repetitions of 5 different exercises: Leg extension, leg press, hip abduction, squat and plantar flexion. Training sessions will be closely supervise and take place twice a week. It is hypothesize that the training program will induce muscular hypertrophy despite the genetic defect. The training program should also have positive effects on function. The participants will be evaluated at baseline, week 6, week 12, month 6 and month 9 to quantify the effects of the training program and if these effects will be maintained over time. | Myopathies | NA | À vérifier | Canada | À vérifier |
| PET scan metabolic dayThe objective of this study is to nake a comparison between 11c-acetate and 11c-acetoacetate kidney uptake in chronic kidney failure patients. | Maladie rénale chronique | À vérifier | À vérifier | Canada | À vérifier |
Essais cliniques
2| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| PET scan metabolic day | Maladie rénale chronique | À vérifier | NCT05968391 | Acetoacetate and Acetate Metabolism in Patients With Chronic Kidney Failure.(RENO-TEP) | ACTIVE_NOT_RECRUITING |
| Effects of a 12-week Strength Training Program in Women With Myotonic Dystrophy Type 1 | Myopathies | NA | NCT05400629 | Effects of a 12-week Strength Training Program in Women With Myotonic Dystrophy Type 1 | COMPLETED |
Publications
2| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| Effects of a 12-week Strength Training Program in Women With Myotonic Dystrophy Type 1 | Resistance training in women with myotonic dystrophy type 1: a multisystemic therapeutic avenue. | Neuromuscular disorders : NMD | ||
| Effects of a 12-week Strength Training Program in Women With Myotonic Dystrophy Type 1 | A 12-Week Strength Training Improves Mitochondrial Respiration, HO Emission and Skeletal Muscle Integrity in Women With Myotonic Dystrophy Type 1. | Acta physiologica (Oxford, England) |